{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005383","form_type":"8-K","ticker":null,"cik":"0001537561","company_name":"Arch Therapeutics, Inc.","filed_at":"2025-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.942140+00:00","generated_at":"2026-05-27T00:54:11.011202+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Arch Therapeutics CFO Abrams resigns; CEO Norchi assumes additional officer roles","bullets":["Michael S. Abrams resigned as CFO and Treasurer effective Feb 3, 2025, and waived contract claims.","CEO Terrence W. Norchi appointed Principal Accounting Officer and Treasurer same day.","Norchi continues as CEO, Chairman, President, and Secretary of the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005383","json":"https://secwatch.observer/filing/0001493152-25-005383.json","markdown":"https://secwatch.observer/filing/0001493152-25-005383.md","text":"https://secwatch.observer/filing/0001493152-25-005383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:54:11.011202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aef38566d3","claim":"Michael S. Abrams resigned as Chief Financial Officer and Treasurer at Arch Therapeutics, Inc..","evidence_excerpt":"On February 3, 2025, Michael S. Abrams, Chief Financial Officer and Treasurer of Arch Therapeutics, Inc. (the “Company”), resigned from his positions with the Company, effective immediately, and has waived any potential rights or claim to any financial obligations under his employment contract.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"ce8264d9bc","claim":"Terrence W. Norchi was appointed as Principal Accounting Officer and Treasurer at Arch Therapeutics, Inc..","evidence_excerpt":"Effective February 3, 2025, the Company has appointed Terrence W. Norchi, who serves as the Company’s Chief Executive Officer, Chairman, President and Secretary, to the roles of Principal Accounting Officer and Treasurer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1537561/000149315225005383/0001493152-25-005383-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}